View More View Less
  • 1 Shiraz University of Medical Sciences Department of Pharmacology PO Box 71345-1649 Shiraz Iran
  • 2 Shiraz University of Medical Sciences Department of Surgery, Division of Cardiovascular Surgery Shiraz Iran
  • 3 Shiraz University of Medical Sciences Medicinal and Natural Products Chemistry Research Center Shiraz Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Ranolazine is a new antianginal drug that is postulated to act through blocking of cardiac late sodium channels and improvement in cardiac blood flow. The present study has been carried out to investigate its possible effect on microcirculation of normal and diabetic rats’ cardiac muscle.

Supplementary Materials

    • Supplementary material, approximately 218 KB.
  • Barclay KD, Klassen GA, Young C: A Method for detecting chaos in canine myocardial microcirculatory red cell flux. Microcirculation 7, 335–346 (2000)

    Young C. , 'A Method for detecting chaos in canine myocardial microcirculatory red cell flux ' (2000 ) 7 Microcirculation : 335 -346.

    • Search Google Scholar
  • Belardinelli L, Shryock JC, Fraser H: The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction. Eur. Heart J. Suppl. 8, A10–A13 (2006)

    Fraser H. , 'The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction ' (2006 ) 8 . Eur. Heart J. Suppl. : A10 -A13.

    • Search Google Scholar
  • Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 95, 522–528 (1997)

    Chilian W.M. , 'Coronary microcirculation in health and disease. Summary of an NHLBI workshop ' (1997 ) 95 Circulation : 522 -528.

    • Search Google Scholar
  • Fraser H, Belardinelli L, Wang L, Light PE, McVeigh JJ, Clanachan AS: Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J. Mol. Cell Cardiol. 41, 1031–1038 (2006)

    Clanachan A.S. , 'Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts ' (2006 ) 41 J. Mol. Cell Cardiol. : 1031 -1038.

    • Search Google Scholar
  • Hamblin M, Friedman DB, Hill S, Caprioli RM, Smith HM, Hill MF: Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J. Mol. Cell Cardiol. 42, 884–895 (2007)

    Hill M.F. , 'Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy ' (2007 ) 42 J. Mol. Cell Cardiol. : 884 -895.

    • Search Google Scholar
  • Hasenfuss G, Maier LS: Mechanism of action of the new anti-ischemia drug ranolazine. Clin. Res. Cardiol. 97, 222–226 (2008)

    Maier L.S. , 'Mechanism of action of the new anti-ischemia drug ranolazine ' (2008 ) 97 Clin. Res. Cardiol. : 222 -226.

    • Search Google Scholar
  • Jenkins MJ, Edgley AJ, Sonobe T, Umetani K, Schwenke DO, Fujii Y, Brown RD, Kelly DJ, Shirai M, Pearson JT: Dynamic synchrotron imaging of diabetic rat coronary microcirculation in vivo. Arterioscler. Thromb. Vasc. Biol. 32, 370–377 (2012)

    Pearson J.T. , 'Dynamic synchrotron imaging of diabetic rat coronary microcirculation in vivo ' (2012 ) 32 Arterioscler. Thromb. Vasc. Biol. : 370 -377.

    • Search Google Scholar
  • Khazraei H, Mirkhani H, Purkhosrow A: Vasorelaxant effect of ranolazine on isolated normal and diabetic rat aorta: A study of possible mechanisms. Acta Physiol. Hung. 100, 153–162 (2013)

    Purkhosrow A. , 'Vasorelaxant effect of ranolazine on isolated normal and diabetic rat aorta: A study of possible mechanisms ' (2013 ) 100 Acta Physiol. Hung. : 153 -162.

    • Search Google Scholar
  • Komaru T, Kanatsuka H, Shirato K: Coronary microcirculation: physiology and parmacology. Pharmacol. Ther. 86, 217–261 (2000)

    Shirato K. , 'Coronary microcirculation: physiology and parmacology ' (2000 ) 86 Pharmacol. Ther. : 217 -261.

    • Search Google Scholar
  • Lee L, Horowitz J, Frenneaux M: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur. Heart J. 25, 634–641 (2004)

    Frenneaux M. , 'Metabolic manipulation in ischaemic heart disease, a novel approach to treatment ' (2004 ) 25 Eur. Heart J. : 634 -641.

    • Search Google Scholar
  • Li XF, Wang YP: Laser Doppler flowmetry for assessment of myocardial microperfusion in the beating rat heart. Vascul. Pharmacol. 46, 207–214 (2007)

    Wang Y.P. , 'Laser Doppler flowmetry for assessment of myocardial microperfusion in the beating rat heart ' (2007 ) 46 Vascul. Pharmacol. : 207 -214.

    • Search Google Scholar
  • Liang Y, Xie L, Liu XD, Chen WD, Lu T, Xiong Y, Wang GJ: Simple, sensitive and rapid liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the quantitation of ranolazine in rat plasma. Rapid Commun. Mass Spectrom. 20, 523–528 (2006)

    Wang G.J. , 'Simple, sensitive and rapid liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the quantitation of ranolazine in rat plasma ' (2006 ) 20 Rapid Commun. Mass Spectrom. : 523 -528.

    • Search Google Scholar
  • MacInnes A, Fairman DA, Binding P, Rhodes Ja, Wyatt MJ, Phelan A, Haddock PS, Karran EH: The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 93, e26–e32 (2003)

    Karran E.H. , 'The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase ' (2003 ) 93 Circ. Res. : e26 -e32.

    • Search Google Scholar
  • McAdams RM, McPherson RJ, Dabestani NM, Gleason CA, Juul SE: Left ventricular hypertrophy is prevalent in Sprague-Dawley rats. Comp. Med. 60, 357–363 (2010)

    Juul S.E. , 'Left ventricular hypertrophy is prevalent in Sprague-Dawley rats ' (2010 ) 60 Comp. Med. : 357 -363.

    • Search Google Scholar
  • Noorafshan A, Khazraei H, Mirkhani H, Karbalay-Doust S: Stereological study of the diabetic heart of male rats. Lab. Anim. Res. 29, 12–18 (2013)

    Karbalay-Doust S. , 'Stereological study of the diabetic heart of male rats ' (2013 ) 29 Lab. Anim. Res. : 12 -18.

    • Search Google Scholar
  • Sabbah HN, Chandler MP, Mishima T, Suzuki G, Chaudhry P, Nass O, Biesiadecki BJ, Blackburn B, Wolff A, Stanley WC: Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J. Card. Fail. 8, 416–422 (2002)

    Stanley W.C. , 'Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure ' (2002 ) 8 J. Card. Fail. : 416 -422.

    • Search Google Scholar
  • Zhao G, Walsh E, Shryock JC, Messina E, Wu Y, Zeng D, Xu X, Ochoa M, Baker SP, Hintze TH, Belardinelli L: Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs. J. Cardiovasc. Pharmacol. 57, 639–647 (2011)

    Belardinelli L. , 'Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs ' (2011 ) 57 J. Cardiovasc. Pharmacol. : 639 -647.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2020 4 0 0
Oct 2020 0 0 0
Nov 2020 0 4 2
Dec 2020 1 0 0
Jan 2021 2 0 0
Feb 2021 0 0 0
Mar 2021 0 0 0